The p53 tumor suppressor plays a critical role in preventing human cancer. Under normal conditions, p53 is present at low levels and has minimal effect on cell fate. However, in response to stress, p53 becomes activated, leading to increased protein levels and enhanced biochemical capabilities. This activation can result in significant phenotypic changes, including DNA repair, senescence, and apoptosis. This review discusses the mechanisms underlying p53's apoptotic activities and its interactions with regulatory signaling networks. p53's ability to transactivate specific target genes is central to its apoptotic function, with the choice of target genes influenced by covalent modifications and protein-protein interactions. Additionally, transcriptional repression of antiapoptotic genes and transcription-independent activities of p53 also contribute to its apoptotic effects. The review also focuses on the interplay between p53 and key regulatory proteins such as β-catenin and Akt/PKB. Both proteins can regulate p53 and be regulated by it. p53 also interacts with GSK-3β, which links Akt and β-catenin. The balance of these interactions determines the likelihood of a cell becoming cancerous or being eliminated from the replicative pool. The review highlights the complex regulation of p53, including its interactions with other proteins such as Mdm2, and the role of covalent modifications in target gene selection. It also discusses the antiapoptotic effects of p53, such as its ability to enhance DNA repair and prevent apoptosis in some cases. The review concludes that the interplay between p53, β-catenin, and Akt is complex and critical in determining cell fate and cancer development. The balance between these proteins is essential for maintaining cellular homeostasis and preventing cancer.The p53 tumor suppressor plays a critical role in preventing human cancer. Under normal conditions, p53 is present at low levels and has minimal effect on cell fate. However, in response to stress, p53 becomes activated, leading to increased protein levels and enhanced biochemical capabilities. This activation can result in significant phenotypic changes, including DNA repair, senescence, and apoptosis. This review discusses the mechanisms underlying p53's apoptotic activities and its interactions with regulatory signaling networks. p53's ability to transactivate specific target genes is central to its apoptotic function, with the choice of target genes influenced by covalent modifications and protein-protein interactions. Additionally, transcriptional repression of antiapoptotic genes and transcription-independent activities of p53 also contribute to its apoptotic effects. The review also focuses on the interplay between p53 and key regulatory proteins such as β-catenin and Akt/PKB. Both proteins can regulate p53 and be regulated by it. p53 also interacts with GSK-3β, which links Akt and β-catenin. The balance of these interactions determines the likelihood of a cell becoming cancerous or being eliminated from the replicative pool. The review highlights the complex regulation of p53, including its interactions with other proteins such as Mdm2, and the role of covalent modifications in target gene selection. It also discusses the antiapoptotic effects of p53, such as its ability to enhance DNA repair and prevent apoptosis in some cases. The review concludes that the interplay between p53, β-catenin, and Akt is complex and critical in determining cell fate and cancer development. The balance between these proteins is essential for maintaining cellular homeostasis and preventing cancer.